NASDAQ:CGEM

Cullinan Therapeutics, Inc. Common Stock

Stock

USD

Last Close

19.91

26/07 20:00

Market Cap

1.16B

Beta: 0.10

Volume Today

593.36K

Avg: 224.28K

PE Ratio

−4.92

PFCF: −5.42

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-14.19M -	-21.65M 52.61%	-59.46M 174.58%	-67.48M 13.50%	109.19M 261.81%	-153.16M 240.26%
depreciation and amortization	43K -	70K 62.79%	62K 11.43%	53K 14.52%	93K 75.47%	310K 233.33%
deferred income tax		-4K -	233K 5,925%	3.10M 1,229.61%		-31.23M -
stock based compensation		17K -	14.91M 87,605.88%	24.38M 63.48%	27.96M 14.70%	30.44M 8.87%
change in working capital	345K -	135K 60.87%	6.85M 4,974.81%	-3.54M 151.69%	11.18M 415.62%	-339K 103.03%
accounts receivables
inventory
accounts payables	225K -	639K 184%	5.58M 773.40%	-4.83M 186.63%	-509K 89.47%	-167K 67.19%
other working capital	120K -	-504K 520%	1.27M 351.98%	1.29M 1.89%	11.69M 803.01%	-172K 101.47%
other non cash items	252K -	539K 113.89%	7.63M 1,315.58%	67K 99.12%	-275.08M 410,674.63%	19.70M 107.16%
net cash provided by operating activities	-13.55M -	-20.90M 54.23%	-29.77M 42.47%	-43.43M 45.89%	-126.66M 191.63%	-134.28M 6.01%
investments in property plant and equipment	-261K -	-20K 92.34%	-10K 50%	-589.23K 5,792.25%	-1.13M 92.29%	-208K 81.64%
acquisitions net			1.45M -	923K 36.34%	275M 29,694.15%
purchases of investments		-35.38M -	-69.76M 97.18%	-525.81M 653.71%	-377.92M 28.13%	-373.38M 1.20%
sales maturities of investments			62.90M -	192.04M 205.29%	352.93M 83.78%	409.40M 16.00%
other investing activites				-333.77K -	91K 127.26%
net cash used for investing activites	-261K -	-35.40M 13,463.22%	-5.42M 84.69%	-333.77M 6,058.21%	248.97M 174.59%	35.81M 85.62%
debt repayment					-2.20M -	-1.82M 17.05%
common stock issued	1K -	85.72M 8,571,400%	140.14M 63.50%	267.27M 90.71%	6.02K 100.00%	38.93M 646,511.30%
common stock repurchased	-21K -	-378K 1,700%	-213K 43.65%
dividends paid
other financing activites	-9K -	378K 4,300%	213K 43.65%	1.52M 611.74%	-23.74M 1,665.90%	3.65M 115.38%
net cash used provided by financing activities	-29K -	85.72M 295,668.97%	140.14M 63.50%	268.78M 91.80%	-25.93M 109.65%	40.75M 257.14%
effect of forex changes on cash
net change in cash	-13.84M -	29.42M 312.57%	104.95M 256.75%	-108.42M 203.31%	96.38M 188.89%	-57.72M 159.89%
cash at beginning of period	47.67M -	33.83M 29.03%	63.25M 86.95%	168.20M 165.93%	59.77M 64.46%	156.15M 161.24%
cash at end of period	33.83M -	63.25M 86.95%	168.20M 165.93%	59.77M 64.46%	156.15M 161.24%	98.43M 36.96%
operating cash flow	-13.55M -	-20.90M 54.23%	-29.77M 42.47%	-43.43M 45.89%	-126.66M 191.63%	-134.28M 6.01%
capital expenditure	-261K -	-20K 92.34%	-10K 50%	-589.23K 5,792.25%	-1.13M 92.29%	-208K 81.64%
free cash flow	-13.81M -	-20.92M 51.46%	-29.78M 42.38%	-44.02M 47.81%	-127.80M 190.30%	-134.48M 5.23%

All numbers in USD (except ratios and percentages)